Φορτώνει......
Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update
Hepatocellular carcinoma (HCC) accounts for most liver cancers and represents one of the deadliest cancers in the world. Despite the global demand for liver cancer treatments, there remain few options available. The U.S. Food and Drug Administration (FDA) recently approved Lumoxiti, a CD22-targeting...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Biomolecules |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7356171/ https://ncbi.nlm.nih.gov/pubmed/32575752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom10060934 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|